{"id":71222,"date":"2026-03-09T12:02:57","date_gmt":"2026-03-09T12:02:57","guid":{"rendered":"https:\/\/indogenmed.org\/?post_type=product&#038;p=71222"},"modified":"2026-08-27T19:24:45","modified_gmt":"2026-08-27T19:24:45","slug":"bevnexxa-100mg-injection","status":"publish","type":"product","link":"https:\/\/indogenmed.org\/fr\/product\/bevnexxa-100mg-injection\/","title":{"rendered":"Bevnexxa 100mg Injection"},"content":{"rendered":"<p>Bevnexxa 100mg Injection est une th\u00e9rapie cibl\u00e9e utilis\u00e9e dans le traitement de certains types de cancer. Son principe actif, bevacizumab, est un anticorps monoclonal humain recombin\u00e9 et humanis\u00e9 qui inhibite le facteur de croissance vasculaire endothelial (VEGF). En bloquant le VEGF, Bevnexxa contribue \u00e0 r\u00e9duire l&rsquo;apport sanguin aux tumeurs, ce qui ralentit ou emp\u00eache leur croissance. Elle est couramment utilis\u00e9e en association avec une chimioth\u00e9rapie pour le cancer colorectal m\u00e9tastatique, le cancer du poumon non \u00e0 petites cellules et le glioblastome. Bevnexxa 100mg Injection est administr\u00e9 par voie intraveineuse par un professionnel de sant\u00e9. Les patients doivent informer leur m\u00e9decin de toute affection m\u00e9dicale pr\u00e9existante, en particulier les maladies cardiaques, l&rsquo;hypertension ou une histoire de troubles h\u00e9morragiques, car ces facteurs peuvent influencer le traitement. Les effets ind\u00e9sirables possibles incluent l&rsquo;hypertension, la prot\u00e9inurie et la cicatrisation retard\u00e9e. Conserver l&rsquo;injection \u00e0 temp\u00e9rature ambiante et la prot\u00e9ger de la lumi\u00e8re. Ne pas congeler.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bevnexxa 100mg Injection est une th\u00e9rapie cibl\u00e9e utilis\u00e9e dans le traitement de certains types de cancer. Son principe actif, bevacizumab, est un anticorps monoclonal humain recombin\u00e9 et humanis\u00e9 qui inhibite le facteur de croissance vasculaire endothelial (VEGF). En bloquant le VEGF, Bevnexxa contribue \u00e0 r\u00e9duire l&rsquo;apport sanguin aux tumeurs, ce qui ralentit ou emp\u00eache leur [&hellip;]<\/p>\n","protected":false},"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[3139],"product_cat":[16212,16213,15891],"product_tag":[15984,17322,15985,15986],"igm_manufacturer":[],"class_list":["post-71222","product","type-product","status-publish","product_brand-celon-laboratories","product_cat-cancer-inhibitors","product_cat-chemotherapy-medicines","product_cat-oncology","product_tag-bevacizumab","product_tag-bevnexxa","product_tag-injection","product_tag-vial","pa_brand-name-bevnexxa","pa_molecule-bevacizumab","first","instock","shipping-taxable","purchasable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/product\/71222","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/comments?post=71222"}],"wp:attachment":[{"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/media?parent=71222"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/product_brand?post=71222"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/product_cat?post=71222"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/product_tag?post=71222"},{"taxonomy":"igm_manufacturer","embeddable":true,"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/igm_manufacturer?post=71222"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}